scispace - formally typeset
Search or ask a question

How does SRAS-CoV-2 replication? 


Best insight from top research papers

SARS-CoV-2 replication involves several key steps. The virus activates the host p38 mitogen-activated protein kinase (MAPK) pathway, which plays a role in inflammatory cytokine production . Additionally, the virus is subject to restriction by interferon-inducible host proteins, such as receptor transporter protein 4 (RTP4) . Single-molecule RNA-fluorescence in situ hybridization (smRNA-FISH) analysis has shown that viral genomic and subgenomic RNAs (gRNA and sgRNA) are synthesized within replication organelles (ROs) in infected cells . The replication of the viral genome is performed by the viral RNA-dependent RNA polymerase, which exhibits high efficiency and unique enzymatic reactivity . Molecular dynamics simulations have revealed the dynamic translocation of the nascent-template duplex during replication, involving asynchronous and rate-limiting movements of the nucleotides . These insights into SARS-CoV-2 replication provide a basis for understanding the virus's molecular events and identifying potential therapeutic targets .

Answers from top 4 papers

More filters
Papers (4)Insight
The paper provides insights into the translocation dynamics of SARS-CoV-2 RdRp during viral replication and transcription, but it does not specifically explain how SARS-CoV-2 replication occurs.
The paper provides a mechanistic resolution of SARS-CoV-2 genome replication. It highlights the high efficiency of the viral RNA-dependent RNA polymerase and its unusual enzymatic reactivity.
The paper provides insights into the kinetics of early post-entry events of SARS-CoV-2 replication, including the formation of replication organelles (ROs) and the synthesis of genomic and subgenomic RNAs (gRNA and sgRNA) within these structures.
The paper states that SARS-CoV-2 hijacks the host p38β/MAPK11 pathway to promote its replication in infected cells.

Related Questions

What is the copy number of all sars-cov-2 structural proteins?5 answersThe copy number of structural proteins in SARS-CoV-2 varies. The virus contains four main structural proteins: spike (S), envelope (E), membrane (M), and nucleocapsid (N). Studies have shown that mutations in these proteins can lead to the emergence of new variants with different characteristics. The most frequent mutations in these proteins include D614G, T9I, I82T, R203M/R203K, and others, with D614G being the most common mutation globally. The spike protein has been found to exhibit the highest number of mutations among the structural proteins, followed by nucleocapsid, envelope, and membrane proteins. These mutations can impact the virus's structure, function, infectivity, and response to drugs and vaccines, highlighting the importance of monitoring and understanding the variations in these structural proteins for effective drug and vaccine development strategies.
What are the key characteristics of the SARS-CoV-2 variant?5 answersThe SARS-CoV-2 variant, known as XBB, exhibits unique characteristics. It originated through recombination of BA.2 lineages, BJ.1 and BM.1.1.1, showing increased resistance to breakthrough infections and enhanced fusogenicity. Subsequent subvariants like XBB.1.16 have emerged with additional mutations in the spike protein, leading to higher transmissibility and immune evasion, making them resistant to various anti-SARS-CoV-2 antibodies. The virus employs methylation by NSP16 and NSP14 to evade host immunity, with NSP10 playing a crucial role in replication and stability, showing limited mutation susceptibility. These variants pose challenges to existing vaccines and monoclonal antibodies, emphasizing the need for continuous monitoring and adaptation in diagnostic and therapeutic strategies to combat the evolving nature of the virus.
What are the currently circulating SARC-CoV-2- variants?5 answersThe currently circulating SARS-CoV-2 variants include Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), Eta (B.1.525), Iota, Kappa, Mu, and Omicron (B.1.1.529). These variants have different mutations in the receptor binding domain (RBD) region of the viral spike, which can increase transmissibility and/or virulence. The Omicron variant is currently the predominant circulating variant and has been found to have advantageous mutations and genetic recombination, making it more contagious and better at escaping immune responses. The Delta variant has been the most common circulating strain, followed by Alpha, Omicron, and Gamma variants. Vaccinated individuals have also been found to be infected with the Omicron variant, with some requiring hospitalization. These variants have significant implications for public health and require ongoing surveillance and evaluation.
How to replicate S?5 answersReplicating S-phase in DNA replication involves the coordinated assembly of proteins and protein complexes to ensure the correct duplication and transfer of genetic information from the parental cell to the progeny. To replicate S-phase, it is important to identify and analyze S-phase cells using computational methods. Additionally, understanding the concept of replication and the different types of replication used in other scientific disciplines can help clarify the best way to run replications in Software Engineering (SE) experiments. Replication in SE experiments aims to check the results and increase the validity and reliability of the outcomes observed. Successful replication can be achieved by reusing baseline experiment materials, maintaining adequate communication among experimenters and replicators, and considering the acceptable changes in the experimental structure. By following these steps, researchers can replicate S-phase and improve the replication practices in SE experiments.
What are the structures of the protein S of the SARS-CoV-2?4 answersThe Spike (S) protein of the SARS-CoV-2 virus is the main target for vaccine and drug research. Comparative analysis of S protein structures in the Protein Data Bank (PDB) database is performed to understand their functional and evolutionary relatedness. The S protein structures are classified into different variants, and the associated literature is studied to investigate the therapeutics used on the structures. A novel and efficient method called S-PDB is proposed for the analysis and classification of S protein structures. The method identifies protein structures in PDB that are similar to SARS-CoV-2 S protein and uses their amino acid sequences for reliable detection/classification. The structure and functions of different domains of the S protein are presented, and therapeutic compounds targeting specific domains are highlighted. Deletion of residues and mutations in specific regions of the S protein can affect its overall structure.
Is SARS 2 RNA infectious?10 answers

See what other people are reading

Was androgenesis applied to wheat cultivar Fielder?
5 answers
Yes, androgenesis was applied to the wheat cultivar Fielder in the study by Xiaona Liang et al. The research aimed to develop powdery mildew (PM) resistant derivatives of Fielder for genetic transformation purposes. PM resistant lines CB037 and Pm97033 were backcrossed to Fielder, resulting in the development of new lines like NT89, NT90, NT154, and WT48 with Pm21, and line FL347 with PmV. These new lines were assessed for their agronomic traits, regeneration ability, and genetic transformation capacity. Among them, lines FL347, WT48, NT89, and NT154 were identified as having equal or superior regeneration and transformation abilities compared to Fielder, making them suitable replacements for Fielder in wheat gene transfer and genome editing studies.
In which studies was androgenesis applied to wheat cultivar Fielder?
4 answers
Androgenesis was applied to wheat cultivar Fielder in the study by Liang et al., where they developed PM resistant lines NT89, NT90, NT154, and WT48 with Pm21 and line FL347 with PmV through backcrossing PM resistant lines to Fielder. Additionally, the study by Nekrasova and Kalinina discussed factors influencing androgenesis in wheat anther culture, emphasizing the importance of genotype, growing conditions, and nutrient medium formula for efficient androgenesis. Furthermore, Lantos et al. improved in vitro androgenesis in einkorn wheat through stress pre-treatments, enhancing the production of embryo-like structures and regenerating green and albino plantlets. Timonova et al. explored the effect of wheat-alien translocations on androgenesis, showing that the presence of specific translocation chromosomes influenced the efficiency of androgenesis in wheat lines.
Can microglia get infected with influenza a virus h7n7?
5 answers
Microglia, the brain's resident immune cells, can indeed get infected with Influenza A virus (IAV) subtype H7N7. Research has shown that H7N7 infection can lead to microglia-induced neuroinflammation, affecting the central nervous system (CNS). Additionally, studies have demonstrated that both human H1N1 and avian H5N1 influenza viruses can infect microglia, inducing apoptosis, cytopathy, and proinflammatory cytokine production in these cells. Furthermore, neuroinflammation induced by neurotropic H7N7 infection results in long-term impairments in the CNS, affecting hippocampal neuronal morphology and cognitive function. These findings highlight the potential of influenza viruses, including H7N7, to infect microglia and trigger detrimental neuroinflammatory responses in the brain.
What is the inmmune response to canine parvovirosis?
5 answers
The immune response to canine parvovirus infection involves various mechanisms. Canine parvovirus type 1 (CPV1) infection can lead to a reduction in monocyte phagocytosis and impairment of monocyte killing, potentially aiding in immune evasion. Vaccination with CPV vaccines like Vanguard 5L and Nobivac DHPPiL has been shown to significantly increase efficacy and overall health status in pups, providing protection against the virus. Canine parvovirus (CPV) has been explored for oncolytic viral gene therapy, where CPV specifically targets and kills cancer cells without harming normal cells, showcasing its potential in cancer treatment. CPV-2c has been found to evade the type I interferon-mediated immune response in infected cells, affecting the expression of key antiviral proteins and viral replication. Additionally, an attenuated CPV vaccine has demonstrated high rates of immunity in dogs, with successful prevention of virulent CPV infection and minimal interference with other vaccines' immune responses.
What are the effects of cadmium on fungi growth?
5 answers
Cadmium (Cd) impacts fungi growth differently based on the species and Cd concentrations. Research indicates that certain fungi, like Purpureocillium lilacinum, exhibit hyper-tolerance to Cd, with the ability to accumulate Cd on their mycelial surfaces, aiding in bioremediation efforts. In contrast, the study on Eucalyptus grandis and Medicago truncatula shows that arbuscular mycorrhizal fungi (AMF) can mitigate Cd toxicity in plants by reducing Cd translocation, enhancing photosynthetic efficiency, and altering Cd distribution in plant cells. Additionally, the interaction between AMF and salt-tolerant grasses like Astragalus adsurgens under Cd stress demonstrates improved plant biomass, reduced Cd concentrations, and regulated gene expression related to stress responses. Therefore, the effects of Cd on fungi growth vary, with some fungi showing tolerance and others interacting with plants to alleviate Cd toxicity.
What is the pathogenesis of Marfan syndrome?
4 answers
The pathogenesis of Marfan syndrome (MFS) involves genetic mutations, particularly in the FBN1 gene, leading to defective connective tissue synthesis and abnormalities in the TGF-β signaling pathway. These mutations result in the defective formation of microfibrils, increased levels of active TGF-β, and instability in elastic structures, contributing to cardiovascular, ocular, and skeletal manifestations. Mechanosensitive signaling pathways involving proteins like XOR, FAK, p38 MAPK, and Egr-1 are aberrantly activated in MFS, leading to ROS generation and aortic aneurysm formation. Additionally, epigenetic factors such as DNA methylation and histone acetylation play regulatory roles in MFS, further influencing disease development. Overall, the complex interplay of genetic, molecular, and mechanosensitive factors underlies the pathogenesis of Marfan syndrome.
What is the treatment paradigm for multiple myeloma and key future strategies?
5 answers
The treatment paradigm for multiple myeloma (MM) involves the use of immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, with consolidation through autologous stem cell transplant for transplant-eligible patients. Research highlights the importance of targeting specific pathways like the RAS signaling cascade and anti-apoptotic proteins for effective MM treatment. Future strategies include exploring quadruplet combination therapies for transplant-eligible patients, optimizing approaches for frail transplant-ineligible patients, and managing high-risk disease. Additionally, advancements in BCMA-targeting therapies, such as CAR-T cell therapy, show promise for refractory MM patients. Improving the immunological environment and eradicating minimal residual disease are key goals for long-term survival, with ongoing investigations into maintaining MRD negativity and selecting effective treatments based on genetic and clinical analyses.
What was the pipeline that led to discovery of lapatinib?
5 answers
The discovery of lapatinib, a dual EGFR and ERBB-2 tyrosine kinase inhibitor, involved a carefully designed biological evaluation cascade coupled with multidimensional data analysis. Lapatinib was initially identified as a multitargeted inhibitor of phosphoprotein signaling in Trypanosoma brucei, despite lacking EGFR-like tyrosine kinases, through proteome-wide phosphopeptide analysis and affinity chromatography studies. Lapatinib's efficacy against HER2-amplified breast cancer was further explored, showing activity in trastuzumab-refractory cases and in combination with letrozole for ER-positive, HER2-positive breast cancer. However, lapatinib exhibited limited activity against the xenografts of the Pediatric Preclinical Testing Program (PPTP) in vivo panel, suggesting differences in therapeutic targets between adult and pediatric cancers.
What is the pathogenic power of rotavirus and adenovirus in animals according to the WHO?
5 answers
Rotavirus and adenovirus are significant pathogens in animals. Rotavirus, responsible for 80% of viral diarrhea cases in children, causes 140 million cases annually, with a high mortality rate in developing countries. In animals, rotavirus species A (RVA) primarily affects young animals, leading to acute diarrhea and substantial economic losses. On the other hand, adenovirus infections, like in dogs, particularly infectious hepatitis caused by Adenoviridae, exhibit severe pathogenicity, affecting multiple organs and leading to necrosis in the liver and hemorrhages in the gastrointestinal tract. These viruses have the potential to cause significant health issues in animals, highlighting the importance of understanding and monitoring their impact to prevent outbreaks and ensure animal health.
Discuss on how can CRISPR Cas9 threaten the health and evolution?
5 answers
CRISPR-Cas9 technology poses threats to health and evolution through various mechanisms. Firstly, off-target effects of Cas9 in bacterial genomes can lead to undesired gene silencing, impacting bacterial function and potentially causing toxicity. Secondly, the potential for unintended mutations introduced by CRISPR-Cas9 editing can be inherited across generations, as shown in zebrafish studies, raising concerns for long-term genetic consequences. Additionally, the ability of Cas9 to induce genomic instability and disrupt DNA repair mechanisms in human cells highlights safety concerns for clinical applications, emphasizing the need for cautious interpretation of CRISPR/Cas9-based gene editing data. These combined factors underscore the importance of thorough pre-testing for off-target effects and structural variants to mitigate risks associated with CRISPR-Cas9 technology in both health and evolutionary contexts.
What are the different types of haematological malignancy recognised by the world health organisation?
5 answers
The World Health Organization recognizes various types of hematological malignancies, which include myeloid and lymphoid neoplasms. Myeloid neoplasms encompass Myelodysplastic syndromes, myeloproliferative neoplasms, and acute myeloid leukemias. On the other hand, lymphoid neoplasms consist of acute and chronic lymphocytic leukemias, plasma cell neoplasms, myeloma, Hodgkin, and non-Hodgkin lymphomas. These classifications are based on lineage, clinical features, morphological characteristics, and immunophenotyping, aiding in the proper diagnosis and treatment decision-making for hematological malignancies. The identification of specific genetic and cytogenetic abnormalities within these neoplasms is crucial for prognostication and treatment management, highlighting the significance of studying chromosomal abnormalities in hematological malignancies.